These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 11519897

  • 1. Primary focal segmental glomerulosclerosis in children: prognostic factors.
    Martinelli R, Okumura AS, Pereira LJ, Rocha H.
    Pediatr Nephrol; 2001 Aug; 16(8):658-61. PubMed ID: 11519897
    [Abstract] [Full Text] [Related]

  • 2. Cyclophosphamide in the treatment of focal segmental glomerulosclerosis.
    Martinelli R, Pereira LJ, Silva OM, Okumura AS, Rocha H.
    Braz J Med Biol Res; 2004 Sep; 37(9):1365-72. PubMed ID: 15334202
    [Abstract] [Full Text] [Related]

  • 3. A combined low-density lipoprotein apheresis and prednisone therapy for steroid-resistant primary focal segmental glomerulosclerosis in children.
    Hattori M, Chikamoto H, Akioka Y, Nakakura H, Ogino D, Matsunaga A, Fukazawa A, Miyakawa S, Khono M, Kawaguchi H, Ito K.
    Am J Kidney Dis; 2003 Dec; 42(6):1121-30. PubMed ID: 14655182
    [Abstract] [Full Text] [Related]

  • 4. Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal.
    Geary DF, Farine M, Thorner P, Baumal R.
    Clin Nephrol; 1984 Sep; 22(3):109-13. PubMed ID: 6488594
    [Abstract] [Full Text] [Related]

  • 5. Clinical course of primary focal segmental glomerulosclerosis (FSGS) in Turkish children: a report from the Turkish Pediatric Nephrology FSGS Study Group.
    Beşbaş N, Ozaltin F, Emre S, Anarat A, Alpay H, Bakkaloğlu A, Baskin E, Buyan N, Dönmez O, Düşünsel R, Ekim M, Göko F, Gür-Güven A, Kavukçu S, Mir S, Sönmez F.
    Turk J Pediatr; 2010 Sep; 52(3):255-61. PubMed ID: 20718182
    [Abstract] [Full Text] [Related]

  • 6. Focal segmental glomerulosclerosis in adult African Americans.
    Bakir AA, Share DS, Levy PS, Arruda JA, Dunea G.
    Clin Nephrol; 1996 Nov; 46(5):306-11. PubMed ID: 8953119
    [Abstract] [Full Text] [Related]

  • 7. Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up.
    Tune BM, Kirpekar R, Sibley RK, Reznik VM, Griswold WR, Mendoza SA.
    Clin Nephrol; 1995 Feb; 43(2):84-8. PubMed ID: 7736683
    [Abstract] [Full Text] [Related]

  • 8. Fractional excretion of high- and low-molecular weight proteins and outcome in primary focal segmental glomerulosclerosis.
    Deegens JK, Wetzels JF.
    Clin Nephrol; 2007 Oct; 68(4):201-8. PubMed ID: 17969486
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Focal segmental glomerulosclerosis in children.
    Jellouli M, Abidi K, Askri M, Ferjani M, Naija O, Hammi Y, Goucha R, Gargah T.
    Tunis Med; 2016 May; 94(5):356-359. PubMed ID: 27801486
    [Abstract] [Full Text] [Related]

  • 11. Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents.
    Griswold WR, Tune BM, Reznik VM, Vazquez M, Prime DJ, Brock P, Mendoza SA.
    Nephron; 1987 May; 46(1):73-7. PubMed ID: 3600915
    [Abstract] [Full Text] [Related]

  • 12. [Clinical and pathological characteristics of focal segmental glomerulosclerosis in children].
    Huang JP, Zhang JJ, Liu JC, Chen YN, Yao Y, Xiao HJ, Yang JY.
    Zhonghua Er Ke Za Zhi; 2004 Jul; 42(7):516-9. PubMed ID: 15324571
    [Abstract] [Full Text] [Related]

  • 13. Primary focal segmental glomerular sclerosis in children: clinical course and prognosis.
    Paik KH, Lee BH, Cho HY, Kang HG, Ha IS, Cheong HI, Jin DK, Moon KC, Choi Y.
    Pediatr Nephrol; 2007 Mar; 22(3):389-95. PubMed ID: 17058050
    [Abstract] [Full Text] [Related]

  • 14. Recent Advances in Treatments of Primary Focal Segmental Glomerulosclerosis in Children.
    Han KH, Kim SH.
    Biomed Res Int; 2016 Mar; 2016():3053706. PubMed ID: 27195285
    [Abstract] [Full Text] [Related]

  • 15. Focal glomerulosclerosis in children: an Argentinian experience.
    Tufro-McReddie A, Alvarez E, Arrizurieta E, Repetto H.
    Pediatr Nephrol; 1992 Mar; 6(2):158-61. PubMed ID: 1571212
    [Abstract] [Full Text] [Related]

  • 16. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J.
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [Abstract] [Full Text] [Related]

  • 17. Cyclosporin therapy for steroid resistant nephrotic focal glomerulosclerosis.
    Windom HH, Fisher M, Neale TJ.
    N Z Med J; 1990 Mar 28; 103(886):125-6. PubMed ID: 2320338
    [Abstract] [Full Text] [Related]

  • 18. The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study.
    Banfi G, Moriggi M, Sabadini E, Fellin G, D'Amico G, Ponticelli C.
    Clin Nephrol; 1991 Aug 28; 36(2):53-9. PubMed ID: 1934660
    [Abstract] [Full Text] [Related]

  • 19. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
    Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, D'Agati VD.
    Kidney Int; 2003 Oct 28; 64(4):1232-40. PubMed ID: 12969141
    [Abstract] [Full Text] [Related]

  • 20. A clinicopathologic study of primary focal segmental glomerulosclerosis in children.
    Lanewala A, Mubarak M, Kazi JI, Akhter F, Sher A, Fayyaz A, Bhatti S.
    Saudi J Kidney Dis Transpl; 2012 May 28; 23(3):513-20. PubMed ID: 22569437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.